Patients' perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes.

Leanne J KosseGerda WeitsHarald E VonkemanSander W TasFrank HoentjenMartijn Bastiaan Adriaan van DoornPhyllis I SpulsGeert R A M D'Haens Michael T Nurmohamed Eugene P van PuijenbroekBart Jf Van Den BemtNaomi T Jessurun

Published in: Expert opinion on drug safety (2021)

Patients' perspectives should be considered in the setup of PRO-based CEM studies, as this contributes to data quality and patient centeredness. Since incorporation of patients' perspectives in CEM studies is indispensable, a delicate balance should be found between user-friendliness and study aims.

Keyphrases

patient reported outcomes
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
emergency department
machine learning
oxidative stress